Brosin topical ointment

Brosin is a specialized veterinary pharmaceutical product designed as a topical antibiotic and anti-inflammatory ointment for multiple animal species. The brand is part of the Dechra portfolio, which entered the Mexican market significantly through the acquisition of Laboratorios Brovel. This specific product is primarily manufactured in Mexico to supply the local and regional livestock and pet care markets.

Dechra Pharmaceuticals, the ultimate owner, is a global specialist in veterinary pharmaceuticals headquartered in the United Kingdom. Following its acquisition by EQT Partners in early 2024, Dechra continues to operate as a leading global entity in the animal health sector, focusing on the development, manufacture, and sales of high-quality products for veterinarians worldwide.